Insulin detemir Subcutaneous and NovoLog
Determining the interaction of Insulin detemir Subcutaneous and NovoLog and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin detemir
Brand name: Levemir, Levemir FlexPen, Levemir PenFill, Levemir InnoLet, Levemir FlexTouch
Synonyms: Insulin detemir, Insulin Detemir
Generic Name: insulin aspart
Brand name: NovoLog, NovoLog FlexPen, NovoLog PenFill, Fiasp, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Novolog
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin detemir Subcutaneous-NovoLog FlexPen
- Insulin detemir Subcutaneous-Novolog Injection
- Insulin detemir Subcutaneous-NovoLog Mix 70/30
- Insulin detemir Subcutaneous-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Insulin detemir Subcutaneous-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Insulin detemir Subcutaneous-NovoLog Mix 70/30 FlexPen
- NovoLog-Insulin glargine
- NovoLog-Insulin Glargine (U-100) Cartridge Systems and Pens
- NovoLog-Insulin Glargine (U-100) Vials
- NovoLog-Insulin Glargine (U-300) Pens
- NovoLog-Insulin glargine and lixisenatide
- NovoLog-Insulin glargine and lixisenatide Subcutaneous